14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 62 days ( -1.45 % )
Last Price $3.49 0 %
High/ Low $3.49 - $3.49 0%
Chg 7 Days N/A $3.49 $3.49
Chg 30 Days N/A $3.49 $3.49
Chg 12 mos 399.50 % $0.699 $3.49
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 219.12 % Width: 124.57 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $8.35 - $18.75 139.26 % - 437.31 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Buy Dec 20, 2023 - 59 days
Short MA avg 12 mos Buy Dec 14, 2023 - 63 days
Long MA avg 12 mos Buy Feb 28, 2024 - 13 days
Short/Long MA avg 12 mos Buy Feb 28, 2024 - 13 days
Pivot Short Sell Mar 14, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Neoleukin Therapeutics Inc

Neoleukin Therapeutics Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aqui... NLTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT